Sharechat Logo

Forum Archive Index - May 2004

Please note usage of the Forum is subject to the Terms & Conditions.

Messages by Date [ Next by Date Previous by Date ]
Messages by Thread [ Next by Thread Previous by Thread ]
Post to the Forum [ New message Reply to this message ]
Printable version

Re: [sharechat] VSG - Related Info only

From: "Cristine Kerr" <>
Date: Wed, 12 May 2004 11:33:07 +1000

German deal to boost Funhaler sales
Posted on Thursday, March 11 @ 07:02:45 EST by shaboo

PERTH biotech Visiomed's Funhaler children's asthma device is poised to break into Europe after the company's first international development alliance with a German drug company

Pari, one of the world's first companies to develop devices that deliver inhaled medications, has struck an agreement to collaborate with Visiomed in adapting the Funhaler for sale in Europe.

The Funhaler, which incorporates a whistle and a glow-in-the-dark spinning disc, was developed by Perth molecular oncologist and Visiomed director Paul Watt, as a fun and easy way to encourage his two children to take their asthma medications.

But while it is the only device of its kind worldwide, Visiomed chief executive Saliba Sassine said he recognised it would be difficult to displace other inhalers in the marketplace.

Instead, Visiomed hopes to sell InfaMed, its paediatric respiratory devices arm, or license the Funhaler technology to established companies like Pari.

"People are going to trust their own products," Mr Sassine said. "But there is no reason we can't do a deal and get the royalties."

A $1 million Funhaler study, funded by the US National Institutes of Health and conducted by asthma researchers at the University of Western Australia and the Telethon Institute for Child Health Research, would further support the device, Dr Sassine said.

A previous study found that 73 per cent of parents reported successfully medicating their children with the Funhaler compared with 10 per cent of conventional spacer users.

It also showed parents were more likely to give the medication because it was a less stressful experience for both the child and the parent.

Visiomed is finalising production details for the Funhaler with Australian manufacturers and has entered collaborative agreements with asthma foundations around Australia to promote the product.

It expects to launch the Funhaler later this year.

Visiomed also anticipates FDA approval and is negotiating with a number of US companies to license out its technology or sell InfaMed.

Shares in the company, which is also involved in medical imaging, have traded between 2.6˘ and 6.9˘ over the past year. They closed yesterday down 0.2˘ at 6.7˘, valuing Visiomed at about $11.8 million.
----- Original Message -----
Sent: Tuesday, May 11, 2004 3:17 PM
Subject: Re: [sharechat] VSG - Related Info only

It's another slow day, so here's some related market info (if you have time on your hands):

Independent Online
' ... Local News
Web posted on May 6, 2004 at 9:00:00 AM CET
Early detection of melanoma through self-examination can save lives
Angele Spiteri Paris
... As summer approaches, and more flesh is bared, the need to raise awareness on the danger of skin cancer becomes more and more vital. If detected early, malignant melanoma, the worst and most fatal type of skin cancer, can be easily treated by surgery.
However, if given time to spread, this cancer is even more deadly than other cancers since it does not respond to any other type of treatment, such as radiotherapy, said Malta Association of Dermatology and Venereology (MADV) president Joseph Pace. ...

... Dr Pace explained that melanoma is the most serious form of skin cancer, in terms of mortality. It can develop anywhere on the skin and in 30-40 per cent of cases this occurs within a pre-existing mole. It is most common for men to develop this type of cancer on their backs, while women’s legs are more susceptible to it, continued Dr Pace. Any new or pre-existing mole that changes shape or colour, or begins to itch, bleed or ooze must be checked immediately, he said. ...

... It is a common belief that melanoma can only develop on areas exposed to the sun. Dr Pace and the other two doctors speaking at the conference, quashed this notion, explaining that an irregular mole on any part of the body can become malignant and should therefore be treated with suspicion. ...

... Dr Boffa did not hesitate to remind the public that it is not sun exposure alone that causes melanoma, it is simply one of the known triggers. ... '

Resesarch and Markets
6 May 2004
' ... Malignant melanoma is the deadliest form of skin cancer and is diagnosed in approximately 132,000 people worldwide each year (2000 data). The incidence of melanoma is increasing at a rate of 3- 5% per year. According to the American Cancer Society, the lifetime risk of malignant melanoma in the U.S. has risen from 1/1,500 people in 1935 to 1/74 people in 2000, with a forecast of 1/50 people by 2005. Melanoma currently affects nearly 200,000 people and in 1997 there were an estimated 40,300 new cases and 7,300 deaths. While melanoma is 85- 90% curable if identified and treated in its earliest stages, melanoma that has metastasized is deadly. Even after surgical removal, the five- year survival rate for metastatic melanoma is only 20- 50%. ... '

Melanoma Monday
3 May 2004
' ... According to the American Cancer Society, some 55,000 new cases of melanoma--the deadliest form of skin cancer--will be diagnosed in 2004, and nearly 8,000 people are expected to die from it this year. On Monday, May 3, Sioux Falls dermatologists are offering free skin-cancer screenings at Lewis Drug at 41st Street and Minnesota Avenue. ... ',31708

NI youngsters warned of sun exposure dangers
10 May 2004
' ... Sandra Gordon, Melanoma Strategy Co-ordinator, said: “Malignant melanoma rates have risen remarkably in Northern Ireland over the past 25 years from an average of 48 cases per year in the mid 70s to 180 cases per year at present ... '

The Scotsman
Mon 10 May 2004
' ... Parents 'ignore cancer warnings over child sunburn'
... Skin-cancer cases have more than doubled in a decade. About 7,000 cases of malignant melanoma - the most serious form of the disease - are diagnosed each year in the UK, with about 1,600 deaths. Malignant melanoma is the third most common cancer among those aged 15 to 24. ... '

May 10, 2004
' ... Sun does damage on spring days, too
By Patricia Hagen
... About 1 million new cases of skin cancer will be diagnosed this year, says the American Academy of Dermatology, which designates May as Melanoma/Skin Cancer Detection & Prevention Month. About 96,000 of the new cases will be melanoma, which will claim the lives of about 7,910 people. ... '

Mirror Co UK
Parents let them burn
By Lorraine Fisher
... skin cancer cases have more than doubled in 10 years. Each year 65,000 patients are diagnosed with the disease in Britain. About 7,000 cases of malignant melanoma - the most serious form - are spotted, with around 1,600 deaths. ... '




Messages by Date [ Next by Date: Re: [sharechat] CBD Calling Cris Cristine Kerr
Previous by Date: Re: [sharechat] CBD Calling Cris Cristine Kerr ]
Messages by Thread [ Next by Thread: Re: [sharechat] VSG - Visiomed - Related Info Cristine Kerr
Previous by Thread: Re: [sharechat] VSG - Related Info only Cristine Kerr ]
Post to the Forum [ New message Reply to this message ]